Luvya Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.06 Cr
- Revenue Growth 3.83%
- Profit Growth -9.82%
- Ebitda 52.79%
- Net Worth 2.65%
- Total Assets 25.49%
About Luvya Medicare
Luvya Medicare Private Limited (LMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 August 2012 and has a history of 12 years and five months. Its registered office is in Dwarka, Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹4.06 Cr.
Vipin Nasa and Seema Nasa serve as directors at the Company.
Company Details
-
Location
Dwarka, Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51397DL2012PTC241246
-
Company No.
241246
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Luvya Medicare Private Limited offer?
Luvya Medicare Private Limited offers a wide range of products and services, including ENT Surgical Equipment & Supplies, Laryngoscope, Thermometers & Flowmeters, Flow Meter, Surgical Equipments, Electrosurgical Unit, Healthcare Products & Aids, Anti Snoring Device, Surgical & ICU Equipments, Ventilator Parts & Consumables.
Who are the key members and board of directors at Luvya Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Nasa
|
Director | 29-Aug-2012 | Current |
|
Seema Nasa
|
Director | 29-Aug-2012 | Current |
Financial Performance of Luvya Medicare.
Luvya Medicare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.83% increase. The company also saw a slight decrease in profitability, with a 9.82% decrease in profit. The company's net worth moved up by a moderate rise of 2.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Luvya Medicare?
In 2023, Luvya Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medlay Healthcare Private LimitedVipin Nasa and Seema Nasa are mutual person
-
Sarv Lifesciences Private Limited
Seema Nasa is a mutual person
Charges (Loans)
₹4.06 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.96 Cr
- Bank Of India : 1.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2022 | Others | ₹1.66 Cr | Open |
| 19 May 2017 | Others | ₹1.30 Cr | Open |
| 14 Jan 2013 | Bank Of India | ₹1.10 Cr | Open |
How Many Employees Work at Luvya Medicare?
Unlock and access historical data on people associated with Luvya Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Luvya Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Luvya Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.